Showing posts with label Biotechnology. Show all posts
Showing posts with label Biotechnology. Show all posts

Friday, 10 January 2020

Single-Cell Genome Sequencing Market 2025 In-Depth Analysis By Key Benefits, Capacity, Outlook And Dynamics


San Francisco, CA - Single-Cell Genome Sequencing Market size is expected to reach USD 2.49 billion by 2025. Single-cell genome sequencing implies analyzing the sequence data with enhanced next-generation sequencing proficiency from a cell. It is a potent instrument that aims to offer intelligence and understanding of genetics by carrying the examination of genomes to the cellular stage. The single-cell genome sequencing technique has a vast effect on various fields of biology comprising cancer research, immunology microbiology, neurobiology, and tissue mosaicism.

Factors such as high cost, and analytical challenges in measurement of the single molecule of DNA may hinder the development of the market in the years to come. The Single-cell genome sequencing market is anticipated to grow at a significant CAGR of 14.6% in the upcoming period as the scope, product types and its applications are increasing across the globe.

The market may be explored by product, technology, workflow, disease area, applications, end users, and geography. Single-cell genome sequencing Market may be explored by product as Instruments, and Reagents. The “Instrument” segment dominated the Single-cell genome sequencing in 2016 and is anticipated to maintain its dominance by 2025. Growth and implementation of technically progressive solutions and instruments is anticipated to propel the development of the segment in the years to come.

The market may be explored by Technology as MDA, PCR, qPCR, Microarray, and NGS. The NGS segment is dominated the segment technology of the Single-cell genome sequencing in 2016. And it is anticipated to maintain its dominance by 2025. Single-cell genome sequencing Market may be explored by workflow as Sample preparation, Isolation, and Genomic analysis. Single-cell genome sequencing Market may be explored by disease as Immunology, Cancer, Prenatal diagnosis, Microbiology, Neurobiology, and Others.

The “Cancer” segment dominated the market in 2016 and anticipated to maintain its dominance by 2025. Growing occurrence of colorectal, breast cancer and prostate are poised to generate profitable development opportunities. Single-cell genome sequencing Market may be explored by applications as Differentiation/ reprogramming, Subpopulation characterization, Genomic variation, CTCs, and Others. The CTCs segment dominated the Single-cell genome sequencing in 2016 and is anticipated to maintain its dominance by 2025.

Regional Analysis For Single-Cell Genome Sequencing Market:
For comprehensive understanding of market dynamics, the global Single-Cell Genome Sequencing Market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Significant Features that are under Offering and Key Highlights of the Reports:
1         Detailed overview of Single-Cell Genome Sequencing Market
2         Changing market dynamics of the industry
3         In-depth market segmentation by Type, Application etc
4         Historical, current and projected market size in terms of volume and value
5         Recent industry trends and developments
6         Competitive landscape of High-Performance Alloys Market
7         Strategies of key players and product offerings
8         Potential and niche segments/regions exhibiting promising growth.


Research Antibodies Market Future Trends, Outlook And Risk Factor By 2025


San Francisco, CA - Research Antibodies Market size is expected to reach USD 4.30 billion by 2025. Antibodies are secreted immunoglobin molecules mainly produced by plasma cells. They are a part of the body’s immune system. The normal function of antibodies is to latch onto antigens and flag them for destruction, thus helping to fight infection. The market is driven by increasing R&D collaborations among various private & public organizations to promote technical advancements in disease progression and product development activities. The market size is expected to expand at a CAGR of 6.1% in the upcoming period.

In research antibodies, some technologies are used such as Immunohistochemistry, Western Blotting, Immunofluorescence, Immunoprecipitation, Flow Cytometry, ELISA, and others. The “western blotting” segment held largest market share in 2016 and is expected to hold the highest market share in the upcoming period due to growing prevalence of diseases with limited treatment options such as HIV. Western blotting is used in research activities conducted by pharmaceutical & biotechnology companies as well as academic institutes.

Product type such as primary and secondary could be explored in research antibodies industry. Primary antibodies were the most leading product type in 2016 due to greater specificity leading to increased adoption in research activities. The segment is anticipated to grow at the highest CAGR during the forecast period owing to the increasing adoption of reagents containing primary research antibodies due to its related benefits such as greater specificity, easy availability and suitability to various research needs.

The factors that play an important role in the growth of research antibodies market include increasing demand, growing population, increasing urbanization & industrialization, increasing funding for proteomics research & drug discovery, growing R&D activities & expenditure in the life science industry, increasing demand for personalized medicine & protein therapeutics, technological advancements and stringent government rules & regulations. Moreover, increasing prevalence of breast cancer and rising need for personalized medicine is stirring up the demand for advanced techniques, which is creating ample growth of the market.

However, the quality concerns over research antibodies, time & cost intensive antibody development processes and the pricing pressures faced by market players are negatively impacting the growth of research antibodies industry. The market is widely analyzed based on different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and others. The market is categorized based on product, type, technology, source, application, end-use and geography.

Regional Analysis For Research Antibodies Market:
For comprehensive understanding of market dynamics, the global Research Antibodies Market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Significant Features that are under Offering and Key Highlights of the Reports:
1         Detailed overview of Research Antibodies Market
2         Changing market dynamics of the industry
3         In-depth market segmentation by Type, Application etc
4         Historical, current and projected market size in terms of volume and value
5         Recent industry trends and developments
6         Competitive landscape of High-Performance Alloys Market
7         Strategies of key players and product offerings
8         Potential and niche segments/regions exhibiting promising growth.

For More Technical Insights, Download Brochure @ https://www.millioninsights.com/industry-reports/research-antibodies-market


Friday, 3 January 2020

Molecular Cytogenetics Market Segmentation, Dynamics And Top Key Vendors To 2025


San Francisco, CA - Molecular Cytogenetics Market is estimated to develop at a substantial CAGR for the duration of the prediction period. With reference to the latest study report by the Grand View research Inc., the global Molecular Cytogenetics market is likely to extend USD 3.8 billion by the completion of the prediction period. Plotting of humanoid genome combined with incessant technical progressions in cytogenetic methods, has allowed investigators to increase understanding into the sickness producing mechanism at a genomic along with cellular level. Progress in molecular knowledge has assisted in linking the gap amongst molecular biology and cytogenetics. It was not conceivable by means of conservative cytogenetic methods.


The division of the Molecular Cytogenetics industry on the source of Type of Technology could span Karyotyping [Virtual Karyotyping, Spectral Karyotyping], Fluorescence in Situ Hybridization [FISH], Immunohistochemistry, Comparative Genomic Hybridization [Standard comparative genomic hybridization, Array-based comparative genomic hybridization], and Other Technology.


The division of the international market of Molecular Cytogenetics on the source of Type of Product could span Software & Services, Instruments, Consumables. The division of the global Molecular Cytogenetics market on the source of Type of End Use could span Pharmaceutical and Biotechnology Companies, Hospitals & Pathology Laboratories, Academic Research Institutes, Clinical & Research Laboratories, and Other End Uses.

The subdivision of clinical & research laboratories had controlled the market in 2016. This is mainly owing to increasing application of cytogenetic methods in clinical analysis. Continuing research relating to pathways underlying numerous chromosomal sicknesses has permitted this subdivision to achieve the biggest stake. The division of the international market of Molecular Cytogenetics on the source of Type of Application could span Personalized Medicine, Genetic Disorders, Oncology and Other Applications.

The division of the international market of Molecular Cytogenetics on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage of Molecular Cytogenetics could span North America, Europe, Asia Pacific, Latin America and Middle East and Africa. By the source of geography, North America was responsible for the biggest stake in 2016 mostly because of the existence of important native entities, for example Agilent Technologies, Inc. Furthermore, existence of actual governing background for the directive of genetic tests has considerably boosted the provincial market.

Asia Pacific is likely to appear such as the speedily developing local market for the duration of the prediction. Incessant progress in GDP of nations like India and China is expected to improve the purchasing capacity of customers and motivate the local development. Continuing works and interferences in Asia Pacific relating to present tendencies, progresses in human genetics & sickness administration are motivating the market in Asia. These workspaces are intended at refining alertness regarding the importance of progressive diagnostics and treatments between the people.

The statement revises Trades in terms of intake of Molecular Cytogenetics in the international market; particularly in North America, Europe, Asia Pacific, Latin America and Middle East and Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the Molecular Cytogenetics on the international basis are Diagnostic Cytogenetics, Inc.[DCI], Cytogno mix, Applied Spectral Imaging, PerkinElmer Inc., Oxford Gene Technology, Bio-Rad Laboratories, Inc., Biological Industries USA, Inc., Agilent Technologies, Inc., Danaher, Genial Genetics, Cyto Test, Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd., Illumina, Inc., Abbott, Meta Systems, and BIOVIEW.


Regional Analysis For Molecular Cytogenetics Market:
For comprehensive understanding of market dynamics, the global Molecular Cytogenetics Market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Significant Features that are under Offering and Key Highlights of the Reports:
– Detailed overview of Molecular Cytogenetics Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of High-Performance Alloys Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Thursday, 2 January 2020

Cancer Stem Cells Market Is Driven By Trajectory Growth Factors And Analysis


San Francisco, CA - Cancer Stem Cells Market is anticipated to reach USD 1.6 billion by 2025. The market is anticipated to witness a healthy growth rate in the years to come. Cancer stem cells (CSCs) imply immortal and rare cells within a tumor that can both - self-renew and differentiate into several cell types that form the tumor mass. In addition, the growth of Cancer Stem Cells is controlled through numerous signaling pathways, which control the existence and propagation of these cells. Currently, a number of enterprises are proceeding toward exploration of exact targets that can be used to selectively remove cancer stem cells; thereby causing therapeutic benefits to patients suffering from many forms of cancers.
On the other hand, factors that may hamper the market growth include high costs of cancer stem cell therapeutics. The market is anticipated to grow at a significant CAGR of 9.98% in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Cancer stem cells industry may be explored by mode of action, forms, and geography. The market may be explored by mode of action as Targeted Cancerous Stem Cells (CSCs). By Anti-Cancer Stem Cell Therapeutics the cancer stem cells market could span Pathway Inhibitors (Notch Signaling Pathway, WNT Signaling Pathway, Hedgehog Signaling Pathway, Others), Immuno-evasion & Targeting Tumor Microenvironment, Surface Marker-based, Nanoparticle-based Therapies, and Others). By-Products, the market spans Cell Separation, Cell Culturing, Molecular Analysis, Cell Analysis, and Others)), and by Stem Cell-based Cancer Therapy the cancer stem cells industry spans Allogeneic Stem Cell Transplant and Autologous Stem Cell Transplant.
Cancer stem cells market may be explored by Forms as Liver Cancer, Blood Cancer, Pancreatic Cancer, Colorectal Cancer, Brain Cancer, Bladder Cancer, Lung Cancer, Breast Cancer, and Other Cancer. The Breast cancer segment dominated the market in the cancer stem cells industry in 2016 and is anticipated to maintain its dominance till 2025. Breast cancer accounted forthe highest share in 2016. North America accounted for the major share of the global Cancer Stem Cells market Size Analysis in 2016 and will continue to rule the roost in the forecast period. North America was followed by Asia-Pacific.
Some of the key players that fuel the growth of the cancer stem cells industry include Bionomics; AbbVie, Inc.; Stemline Therapeutics, Inc.; Merck KGaA; Lonza; BIOTIME, INC, MiltenyiBiotec; MacroGenics, Inc.; Irvine Scientific; Thermo Fisher Scientific, Inc.; OncoMed Pharmaceuticals, Inc.; Sino Biological Inc.; STEMCELL Technologies Inc.; and PromoCell GmbH. The leading companies are entering into partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Regional Analysis For Cancer Stem Cells Market:
For comprehensive understanding of market dynamics, the global Cancer Stem Cells Market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Significant Features that are under Offering and Key Highlights of the Reports:
– Detailed overview of Cancer Stem Cells Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of High-Performance Alloys Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:
Ryan Manuel
Research Support Specialist, USA

Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
tel: 91-20-65300184

Tuesday, 31 December 2019

Protein Extracts Market By Emerging Growth Factors, Outlook And Restraints


Felton - Protein Extracts from Single Cell Protein and the Other Conventional Sources Market is expected to reach USD 26.3 Billion by 2025. Protein Extracts from Single Cell Protein and Other Conventional Sources is used to meet the protein need of raising population. The single cell protein (SCP) is termed as a dried microbial cell or total protein extracted from pure microbial cell culture like fungi, algae, bacteria, and yeast specifically grown on agricultural waste and may be used as food supplement to animals and humans. The production of single cell protein can be done using waste materials like corncobs, wood shavings, sawdust, and others. The protein extracts market is expected to grow at a significant CAGR of 8.4% in the forecast period.

High demand for SCP proteins as it has low fat content and contains about 43 to 85% of protein, growing use of enhanced techniques, high demand for nutritious products, and rising population are documented as major factors of Protein Extracts from Single Cell Protein and Other Conventional Sources Market that are estimated to enhance the growth in the years to come. Protein Extracts from Single Cell Protein and Other Conventional Sources Market is segmented based on sources, applications, and region.
Fungi, bacteria, algae, yeast, and other sources could be explored in Protein Extracts from Single Cell Protein and Other Conventional Sources in the forecast period. Plant based protein extracts accounted for the largest market share of Protein Extracts from Single Cell Protein and Other Conventional Sources and is estimated to lead the market in the upcoming years. The Protein Extracts from Single Cell Protein and the Other Conventional Sources market may be categorized based on applications like agriculture & fertilizers, biotechnology, animal feed, and others. The animal feed is sub-segregated into animal feed by animal type and animal feed by grades. Animal feed by animal type includes pet animals, livestock, and fish feed. On the other hand, animal feed by grade includes hydrolysates, concentrates, and isolates. Agriculture protein extracts and animal feed protein extracts accounted for the largest market share of overall market and is estimated to remain dominant in the forecast period. This may be because of high demand for proteins from this section.
Globally, North America accounted for the largest market share of Protein Extracts from Single Cell Protein and Other Conventional Sources in 2016 and is estimated to lead the overall market in the coming years. The reason behind the overall Protein Extracts from Single Cell Protein and the Other Conventional Sources market growth could be, rising use of enhanced biotechnological techniques and presence of key manufacturers in the region. The United States is a major consumer of Protein Extracts from Single Cell Protein and Other Conventional Sources in this region. This may be because, rising research regarding use of microbes as a substitute nutrient source.
Market Segment:
Protein Extracts from Single Cell Protein and Other Conventional Sources Source Outlook (Revenue, USD Million, 2014 - 2025)
    • Plant Protein Extract Sources
    • Microbial Sources - Single Cell Proteins
    • Microbial Sources - Direct Use
Protein Extracts from Single Cell Protein and Other Conventional Sources Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Biotechnology
        • Pharma
        • Cell Culture media
    • Other
Regional Analysis For Protein Extracts Market:
For comprehensive understanding of market dynamics, the global Protein Extracts Market is analyzed across key geographies namely: North America, Europe, Asia-Pacific, Latin America and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Significant Features that are under Offering and Key Highlights of the Reports:
– Detailed overview of Protein Extracts Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc
– Historical, current and projected market size in terms of volume and value
– Recent industry trends and developments
– Competitive landscape of High-Performance Alloys Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:
Ryan Manuel
Research Support Specialist, USA

Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
tel: 91-20-65300184